Skip to content
Tuesday, August 9, 2022
Latest:
  • Genome-wide study reveals new susceptibility genetic variants for lung cancer
  • Don’t get into a tizzy if your water is fizzy
  • The path forward: a more inclusive healthcare system
  • Raising awareness of spina bifida
  • Fertility Series: Advanced maternal age

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

lapatinib

From The Labs 

De-escalating breast cancer therapy; can some patients be spared chemotherapy?

June 25, 2019June 25, 2019Breast Cancer, Chemotherapy, Clinical Trials, HER2 gene, lapatinib, PI3K pathway, Research, trastuzumab

About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive

Read more

From the Labs Video of the Month

From The Labs Image of the Month From the Labs: A beating developing mouse heart.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951